These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 16124001

  • 1. Somatosensory evoked potential and clinical changes after electrode implant in basal ganglia of parkinsonian patients.
    Insola A, Mazzone P, Valeriani M.
    Muscle Nerve; 2005 Dec; 32(6):791-7. PubMed ID: 16124001
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region.
    Yeh IJ, Tsang EW, Hamani C, Moro E, Mazzella F, Poon YY, Lozano AM, Chen R.
    Mov Disord; 2010 Oct 15; 25(13):2076-83. PubMed ID: 20669321
    [Abstract] [Full Text] [Related]

  • 5. Subthalamic somatosensory evoked potentials in Parkinson's disease.
    Pesenti A, Priori A, Locatelli M, Egidi M, Rampini P, Tamma F, Caputo E, Chiesa V, Barbieri S.
    Mov Disord; 2003 Nov 15; 18(11):1341-5. PubMed ID: 14639678
    [Abstract] [Full Text] [Related]

  • 6. Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.
    Anheim M, Batir A, Fraix V, Silem M, Chabardès S, Seigneuret E, Krack P, Benabid AL, Pollak P.
    Arch Neurol; 2008 May 15; 65(5):612-6. PubMed ID: 18474736
    [Abstract] [Full Text] [Related]

  • 7. Unmasking of presynaptic and postsynaptic high-frequency oscillations in epidural cervical somatosensory evoked potentials during voluntary movement.
    Insola A, Padua L, Mazzone P, Valeriani M.
    Clin Neurophysiol; 2008 Jan 15; 119(1):237-45. PubMed ID: 18054280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy.
    McClelland S, Ford B, Senatus PB, Winfield LM, Du YE, Pullman SL, Yu Q, Frucht SJ, McKhann GM, Goodman RR.
    Neurosurg Focus; 2005 Nov 15; 19(5):E12. PubMed ID: 16398462
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease.
    Jech R, Růzicka E, Urgosík D, Serranová T, Volfová M, Nováková O, Roth J, Dusek P, Mecír P.
    Clin Neurophysiol; 2006 May 15; 117(5):1017-28. PubMed ID: 16516544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y, Wilbrink P, Duits A, Boon P, Tromp S, Ackermans L, van Kranen-Mastenbroek V, Weber W, Visser-Vandewalle V.
    Neurosurgery; 2007 Nov 15; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M, Margari L, Lamberti P, Iliceto G, Ferrari E.
    J Neural Transm Suppl; 1995 Nov 15; 45():171-6. PubMed ID: 8748623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.